Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
phesgo 600 mg/600 mg/10 ml solution injectable
roche pharma (schweiz) ag - pertuzumabum, trastuzumabum - solution injectable - pertuzumabum 600 mg, trastuzumabum 600 mg, hyaluronidasum humanum adnr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, saccharum, polysorbatum 20, dl-methioninum, aqua ad iniectabile q.s. ad solutionem pro 10 ml. - le cancer du sein - biotechnologika
Suisse -
français -
Swissmedic (Swiss Agency for Therapeutic Products)
phesgo 1200 mg/600 mg/15 ml solution injectable
roche pharma (schweiz) ag - pertuzumabum, trastuzumabum - solution injectable - pertuzumabum 1200 mg, trastuzumabum 600 mg, hyaluronidasum humanum adnr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, saccharum, polysorbatum 20, dl-methioninum, aqua ad iniectabile q.s. ad solutionem pro 15 ml. - le cancer du sein - biotechnologika